Difficulty: Medium
Average Score: 73%
Practice
Grey baby syndrome is a reported complication of:
Correct answer
B
Rationale
The correct answer is B) Chloramphenicol. Grey baby syndrome is a rare but serious side effect associated with the use of chloramphenicol in newborns and infants. Chloramphenicol can inhibit mitochondrial protein synthesis, leading to toxicity in young infants who have immature liver function, causing a grayish discoloration of the skin, poor feeding, hypothermia, and a gray-colored appearance.
A) Clindamycin is not associated with grey baby syndrome. It is a lincosamide antibiotic commonly used to treat various bacterial infections.
C) Tetracycline can cause tooth discoloration and inhibit bone growth in fetuses and young children but is not linked to grey baby syndrome.
D) Azithromycin is a macrolide antibiotic with a different side effect profile and is not known to cause grey baby syndrome.
Educationally, understanding the side effects and complications of chemotherapy drugs is crucial for nurses and healthcare professionals administering these medications. Recognizing the specific adverse effects associated with each drug can help prevent serious complications and ensure safe patient care. It is important to be vigilant in monitoring patients for any signs of toxicity or adverse reactions when administering chemotherapy drugs to prevent harm and promote positive patient outcomes.
A) Clindamycin is not associated with grey baby syndrome. It is a lincosamide antibiotic commonly used to treat various bacterial infections.
C) Tetracycline can cause tooth discoloration and inhibit bone growth in fetuses and young children but is not linked to grey baby syndrome.
D) Azithromycin is a macrolide antibiotic with a different side effect profile and is not known to cause grey baby syndrome.
Educationally, understanding the side effects and complications of chemotherapy drugs is crucial for nurses and healthcare professionals administering these medications. Recognizing the specific adverse effects associated with each drug can help prevent serious complications and ensure safe patient care. It is important to be vigilant in monitoring patients for any signs of toxicity or adverse reactions when administering chemotherapy drugs to prevent harm and promote positive patient outcomes.